Vinculin Antikörper (AA 12-39)
Kurzübersicht für Vinculin Antikörper (AA 12-39) (ABIN7870291)
Target
Alle Vinculin (VCL) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 12-39
-
Verwendungszweck
- VCL Antibody / Vinculin
-
Aufreinigung
- Purified
-
Immunogen
- A portion of amino acids 12-39 from the human protein was used as the immunogen for the VCL antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- The stated application concentrations are suggested starting points. Titration of the VCL antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the VCL antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Vinculin (VCL)
-
Andere Bezeichnung
- VCL
-
Hintergrund
- VCL/Vinculin is a cytoskeletal protein associated with cell-cell and cell-matrix junctions, where it is thought to function as one of several interacting proteins involved in anchoring F-actin to the membrane. Defects in VCL are the cause of cardiomyopathy dilated type 1W. Dilated cardiomyopathy is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia.
-
UniProt
- P18206
-
Pathways
- Cell-Cell Junction Organization, Maintenance of Protein Location, Signaling Events mediated by VEGFR1 and VEGFR2
Target
-